Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease

Starting soon · Phase 1

Conditions studied: Parkinson Disease

In brief

FMT may significantly improve quality of life and Parkinson Disease (PD) symptom severity measurements. We hypothesize that gut microbial dysbiosis is a major contributing factor in Parkinson's disease.

Key facts

Study ID

NCT06647277

Run by

ProgenaBiome

People needed

10

Starts

2026-07-01

Expected to finish

2027-12-01

Last updated by the study team

2025-06-26

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals diagnosed with PD

You may not qualify if…

• Non-PD individuals

Where it is running

• Sabine Hazan — Ventura, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.